Related Experiment Video
Updated: Mar 23, 2026

Biochemical and Structural Characterization of the Carbohydrate Transport Substrate-binding-protein SP0092
Published on: October 2, 2017
Kinetic and Binding Studies of Streptococcus pneumoniae Type 2 Isopentenyl Diphosphate:Dimethylallyl Diphosphate
Matthew Walter Janczak1, C Dale Poulter1
1Department of Chemistry, University of Utah , 315 South 1400 East, Salt Lake City, Utah 84112, United States.
Abstract:
Type 2 isopentenyl diphosphate:dimethylallyl diphosphate isomerase (IDI-2) converts isopentenyl diphosphate (IPP) to dimethylallyl diphosphate (DMAPP), the two fundamental building blocks of isoprenoid molecules. IDI-2 is found in many species of bacteria and is a potential antibacterial target since this isoform is non-homologous to the type 1 enzyme in Homo sapiens. IDI-2 requires a reduced flavin mononucleotide to form the catalytically active ternary complex, IDI-2·FMNH2·IPP. For IDI-2 from the pathogenic bacterium Streptococcus pneumoniae, the flavin can be treated kinetically as a dissociable cosubstrate in incubations with IPP and excess NADH. Under these conditions, the enzyme follows a modified sequential ordered mechanism where FMN adds before IPP. Interestingly, the enzyme shows sigmoidal behavior when incubated with IPP and NADH with varied concentrations of FMN in aerobic conditions. In contrast, sigmoidal behavior is not seen in incubations under anaerobic conditions where FMN is reduced to FMNH2 before the reaction is initiated by addition of IPP. Stopped-flow experiments revealed that FMN, whether bound to IDI-2 or without enzyme in solution, is slowly reduced in a pseudo-first-order reaction upon addition of excess NADH (k(red)(FMN) = 5.7 × 10(-3) s(-1) and k(red)(IDI-2·FMN) = 2.8 × 10(-3) s(-1)), while reduction of the flavin is rapid upon addition of NADH to a mixture of IDI-2·FMN, and IPP (k(red)(IDI-2·FMN·IPP) = 8.9 s(-1)). Similar experiments with dithionite as the reductant gave k(red)(FMN) = 221 s(-1) and k(red)(IDI-2·FMN) = 411 s(-1). Dithionite reduction of FMN in the IDI-2·FMN and IPP mixture was biphasic with k(red)(IDI-2·FMN·IPP (fast)) = 326 s(-1) and k(red)(IDI-2·FMN·IPP (slow)) = 6.9 s(-1) The pseudo-first-order rate constant for the slow component was similar to those for NADH reduction of the flavin in the IDI-2·FMN and IPP mixture and may reflect a rate-limiting conformational change in the enzyme.
Insights
Type 2 isopentenyl diphosphate:dimethylallyl diphosphate isomerase (IDI-2) is a bacterial enzyme and potential antibacterial target. Its activity is modulated by flavin mononucleotide (FMN) reduction, with reaction kinetics influenced by oxygen levels and substrate binding.
Area of Science:
- Biochemistry
- Enzymology
- Antimicrobial drug discovery
Background:
- Type 2 isopentenyl diphosphate:dimethylallyl diphosphate isomerase (IDI-2) synthesizes essential isoprenoid precursors.
- IDI-2 is a non-human homolog and potential target for novel antibacterial agents.
- The enzyme requires reduced flavin mononucleotide (FMNH2) for catalysis, forming an IDI-2·FMNH2·IPP complex.
Purpose of the Study:
- To elucidate the kinetic mechanism of Streptococcus pneumoniae IDI-2.
- To investigate the role of flavin mononucleotide (FMN) reduction in IDI-2 activity.
- To explore the impact of aerobic and anaerobic conditions on enzyme kinetics.
Main Methods:
- Enzyme kinetics assays using varying substrate and cofactor concentrations.
- Stopped-flow spectrophotometry to monitor flavin reduction rates.
- Comparative analysis of reaction rates under aerobic and anaerobic conditions.
Main Results:
- IDI-2 follows a modified sequential ordered mechanism with FMN binding before IPP.
- Aerobic conditions with NADH and IPP lead to sigmoidal kinetics with respect to FMN concentration.
- Flavin reduction rates are significantly slower under aerobic conditions compared to anaerobic conditions or dithionite reduction.
- A rate-limiting conformational change may occur during NADH-dependent flavin reduction in the presence of IPP.
Conclusions:
- The catalytic mechanism of IDI-2 is sensitive to oxygen availability and substrate binding.
- Understanding these kinetic properties is crucial for developing IDI-2 as an antibacterial target.
- The observed sigmoidal kinetics suggest complex regulatory mechanisms potentially exploitable for drug design.
More Related Videos
10:31A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA2
Published on: September 26, 2025
09:53A Purification and In Vitro Activity Assay for a pppGpp Synthetase from Clostridium difficile
Published on: November 3, 2018